Concepedia

Jeffrey E. DeClue

JE

Statistics

Publications

36

Citations

3.4K

H-Index

29

Active since

1985

Affiliations

National Cancer Institute(Current)

University of California, Berkeley

National Institutes of Health

Ludwig-Maximilians-Universität München

Washington University in St. Louis

Jeffrey E. DeClue is an author at National Cancer Institute specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

1985–2006

36

Publications

36

Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY

Ralf Wienecke, Adrian König, Jeffrey E. DeClue · Journal of Biological Chemistry · 1995 · 356 citations · Full text

The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination

Giovanna Benvenuto, Shaowei Li, Samantha J Brown et al. · Oncogene · 2000 · 255 citations

, , +7

Identification and characterization of the neurofibromatosis type 1 protein product.

Jeffrey E. DeClue, Bruce D. Cohen, Douglas R. Lowy · Proceedings of the National Academy of Sciences · 1991 · 212 citations · Full text

, , +20

Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control

Thomas Soucek, Oliver Pusch, Ralf Wienecke et al. · Journal of Biological Chemistry · 1997 · 192 citations · Full text

Suppression of c-ras transformation by GTPase-activating protein

Ke Zhang, Jeffrey E. DeClue, William C. Vass et al. · Nature · 1990 · 164 citations

, , +6

1–5 of 36